3rd Quarter - Report

AMERICAN OSTEOPATHIC ASSOCIATION for AMERICAN OSTEOPATHIC ASSOCIATION

Firm
Client
Income
—
Expenses
$116,415
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

9 issue areas, each in the filer's own words, with who lobbied on it and where.

Insurance INS

Health Insurance; Professional Liability Insurance; State Insurance Marketplaces

LobbyistCovered position, as disclosed
HOLLY BIGLOW Government Relations Associate
ADAM BUCKALEW New Government Relations Associate
RAY QUINTERO VP Government Relations
LAURA WOOSTER Associate VP Government Relations

Contacted: Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); Executive Office of the President (EOP); SENATE; HOUSE OF REPRESENTATIVES; Medicare Payment Advisory Commission (MedPAC); Agency for Healthcare Research & Quality (AHRQ); Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); Government Accountability Office (GAO); Food & Drug Administration (FDA); Office of Management & Budget (OMB); White House Office

Budget/Appropriations BUD

Labor HHS Appropriations

LobbyistCovered position, as disclosed
HOLLY BIGLOW Government Relations Associate
ADAM BUCKALEW New Government Relations Associate
RAY QUINTERO VP Government Relations
LAURA WOOSTER Associate VP Government Relations

Contacted: Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); Agency for Healthcare Research & Quality (AHRQ); Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); Medicare Payment Advisory Commission (MedPAC); Executive Office of the President (EOP); Office of Management & Budget (OMB); SENATE; Government Accountability Office (GAO); White House Office; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Defense DEF

Recognition of Osteopathic Certification

LobbyistCovered position, as disclosed
HOLLY BIGLOW Government Relations Associate
ADAM BUCKALEW New Government Relations Associate
RAY QUINTERO VP Government Relations
LAURA WOOSTER Associate VP Government Relations

Contacted: Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); SENATE; Agency for Healthcare Research & Quality (AHRQ); Medicare Payment Advisory Commission (MedPAC); HOUSE OF REPRESENTATIVES; White House Office; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Government Accountability Office (GAO); Health Resources & Services Administration (HRSA); Office of Management & Budget (OMB)

Taxation/Internal Revenue Code TAX

Flexible Spending Accounts; Health Savings Accounts

LobbyistCovered position, as disclosed
HOLLY BIGLOW Government Relations Associate
ADAM BUCKALEW New Government Relations Associate
RAY QUINTERO VP Government Relations
LAURA WOOSTER Associate VP Government Relations

Contacted: Government Accountability Office (GAO); SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); Office of Management & Budget (OMB); Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); White House Office; Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Agency for Healthcare Research & Quality (AHRQ); Medicare Payment Advisory Commission (MedPAC)

Health Issues HCR

Medicare Physician Payments Reform, Patient access to care; Graduate Medical Education. Physician Workforce Issues. Health reform implementation (PL 111-148). Telehealth (Health Information Technology).

LobbyistCovered position, as disclosed
HOLLY BIGLOW Government Relations Associate
ADAM BUCKALEW New Government Relations Associate
RAY QUINTERO VP Government Relations
LAURA WOOSTER Associate VP Government Relations

Contacted: Agency for Healthcare Research & Quality (AHRQ); Medicare Payment Advisory Commission (MedPAC); White House Office; Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); Government Accountability Office (GAO); Office of Management & Budget (OMB); SENATE; Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Food & Drug Administration (FDA); Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Graduate Medical Education; Health Care Quality, Patient Access to Health Care; Physician Workforce; Medicare Physician Payment Issues; Independent Payment Advisory Board. H.R. 574, The Medicare Physician Payment Innovation Act of 2013.

LobbyistCovered position, as disclosed
HOLLY BIGLOW Government Relations Associate
ADAM BUCKALEW New Government Relations Associate
RAY QUINTERO VP Government Relations
LAURA WOOSTER Associate VP Government Relations

Contacted: Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); Government Accountability Office (GAO); Executive Office of the President (EOP); Health Resources & Services Administration (HRSA); Food & Drug Administration (FDA); SENATE; Agency for Healthcare Research & Quality (AHRQ); HOUSE OF REPRESENTATIVES; White House Office; Medicare Payment Advisory Commission (MedPAC); Office of Management & Budget (OMB)

Bills named: H.R. 574 (113th)

Education EDU

Student Loan Financing and Re-Financing

LobbyistCovered position, as disclosed
HOLLY BIGLOW Government Relations Associate
ADAM BUCKALEW New Government Relations Associate
RAY QUINTERO VP Government Relations
LAURA WOOSTER Associate VP Government Relations

Contacted: Government Accountability Office (GAO); White House Office; HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); SENATE; Office of Management & Budget (OMB); Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); Agency for Healthcare Research & Quality (AHRQ); Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Food & Drug Administration (FDA); Medicare Payment Advisory Commission (MedPAC)

Medical/Disease Research/Clinical Labs MED

NIH; FDA; Agency for Health Care Quality & Research Funding

LobbyistCovered position, as disclosed
HOLLY BIGLOW Government Relations Associate
ADAM BUCKALEW New Government Relations Associate
RAY QUINTERO VP Government Relations
LAURA WOOSTER Associate VP Government Relations

Contacted: Food & Drug Administration (FDA); SENATE; Agency for Healthcare Research & Quality (AHRQ); Government Accountability Office (GAO); Executive Office of the President (EOP); White House Office; Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); Medicare Payment Advisory Commission (MedPAC); Office of Management & Budget (OMB); Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Torts TOR

Professional Liability Insurance; Medical Liability Reform

LobbyistCovered position, as disclosed
HOLLY BIGLOW Government Relations Associate
ADAM BUCKALEW New Government Relations Associate
RAY QUINTERO VP Government Relations
LAURA WOOSTER Associate VP Government Relations

Contacted: SENATE; Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Food & Drug Administration (FDA); Government Accountability Office (GAO); Agency for Healthcare Research & Quality (AHRQ); White House Office; Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); Medicare Payment Advisory Commission (MedPAC)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.